Cell & Gene

Cell & Gene operates under Life Science Connect, which helps create connections and encourages partnerships within the pharmaceutical, biotech, and medical device sectors. They achieve this through various channels, including online platforms, publications, events, and training programs.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#726680

United States

#262119

Health/Biotechnology and Pharmaceuticals

#239

Traffic sources

Monthly visitors

Articles

Atsena Therapeutics Advances Gene Therapy For XLRS

3 days ago | cellandgene.com | Erin Harris

By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 While the CGT sector has made significant strides in oncology, its transformative potential extends well beyond cancer. A growing number of companies are advancing CGT approaches for rare and inherited diseases, including those affecting vision.
05.01.25 -- Navigating CGT Biotech's Financial Headwinds And The Path Forward

2 weeks ago | cellandgene.com | Erin Harris

Discover the future of iPSC-based therapies in this free Cell & Gene Live digital event. Experts will share insights on emerging applications, regulatory challenges, gene editing advancements, and key safety considerations in scalable iPSC manufacturing. Don't miss this opportunity to hear from leaders at the forefront of regenerative medicine. Supported by Invetech.
04.28.25 -- Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers

2 weeks ago | cellandgene.com | Nero Haralalka |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino

The ISCT 2025 Scientific Annual Meeting (May 7-10 in New Orleans) is the largest global gathering for KOLs and subject matter experts for driving the clinical translation of cell and gene therapies. The work presented at this conference spans regulatory affairs, workforce development and the entire development pathway from pre-clinical work to Phase 3 clinical trials, CGT product launch and market access.
04.25.25 -- Why You Need A Raw Material Control Strategy

3 weeks ago | cellandgene.com | Christina Bennett |Joe Cintavey |W.L. Gore |Sanjeev Luther

Transforming the Biopharma Supply Chain, eData Solutions for Agility and Manufacturing EfficiencyWatch our engaging webinar to discover how eData empowers biopharma supply chains with process automation, critical analytics, and predictive logistics. Learn how manufacturers can proactively mitigate disruptions and adopt a standardized digital platform for resilient operations here. You should start with the end goal in mind, but the first draft is almost never the last.
04.24.25 -- How Cynata Therapeutics Is Unlocking The Power Of iPSCs To Transform Regenerative Medicine

3 weeks ago | cellandgene.com | Erin Harris |Dan Nelson |CARR Biosystems |Royce Tourtillott

Setting the Standard in CGT: Perspectives on Performance, Scalability, and Regulatory ComplianceExplore the evolving landscape of cell and gene therapy with insights from key opinion leaders. This white paper addresses challenges in process development and manufacturing across different modalities. Discover how end-to-end solutions can accelerate commercialization by prioritizing performance and scalability while simplifying the path to regulatory approvals.
Navigating CGT Biotech's Financial Headwinds and the Path Forward

3 weeks ago | cellandgene.com | Erin Harris

By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 In today’s turbulent biotech landscape, companies are being forced to rethink their strategies across every stage of development. Recently, I had the opportunity to sit down with Dr. Ali Pashazadeh, Founder of Treehill Partners, for a conversation in which he offered a candid and informed perspective on the financial pressures facing the CGT space and the strategic pivots that could help biotechs move forward.
04.16.25 -- Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment

1 month ago | cellandgene.com | Tim Sandle |Louis Cicchini

The 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, gathering 350+ global stakeholders, sharing exclusive scientific and strategic insights from the biggest and newest players in the mRNA field. Register nowFOCUS ON TRANSLATIONAL RESEARCHBy combining drugs/therapies with different mechanisms of action, different pathways in cancer cells can be targeted, potentially leading to improved patient outcomes. Using AI is hastening this research.
How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform Regenerative Medicine

1 month ago | cellandgene.com | Erin Harris

By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 Cynata Therapeutics, a Melbourne, Australia-based regenerative medicine company, is pioneering a new era in cell therapy with its Cymerus platform.
04.08.25 -- 2025 Cell Therapy Outlook From BPI West

1 month ago | cellandgene.com | Tyler Menichiello |Kaitlyn R Rouillard |Rachel Ward

Introducing a new way to source solutions for improving, refining, and optimizing your CGT manufacturing! From April 8-10, Life Science Connect brings you the next virtual showcase from its network of trusted communities: Cell & Gene Therapy Tech Expo.
Emerging Technologies For Cell Therapy Manufacturing

1 month ago | cellandgene.com | Erin Harris

By Erin Harris, Editor-In-Chief, Cell & Gene Follow Me On Twitter @ErinHarris_1 During last month’s Cell & Gene Live, Emerging Technologies for Cell Therapy Manufacturing, I had the pleasure of conversing with our expert panelists, Rohit Ingale, Head of Manufacturing & MSAT at Arcellx and David O’Donnell, Vice President, Head of Manufacturing at Vor Bio about the biggest challenges and promising innovations in cell therapy manufacturing.